Navigation Links
Cell biologist Chris A. Kaiser to lead NIH's National Institute of General Medical Sciences
Date:10/18/2011

National Institutes of Health Director Francis S. Collins, M.D., Ph.D., today announced the selection of Chris A. Kaiser, Ph.D., as the new director of the National Institute of General Medical Sciences. Kaiser, a leader in cell biology, is professor and head of the Department of Biology at the Massachusetts Institute of Technology. He expects to start his new position in the spring of 2012.

"Dr. Kaiser has tremendous energy and enthusiasm for research and trainingtwo key components of the NIGMS missionthat make him ideal for this position," said Collins. "His scientific vision, leadership skills and collaborative spirit are essential assets that will help him guide the institute during this era of great opportunity."

Kaiser will replace Judith H. Greenberg, Ph.D., who became acting director of NIGMS in July 2011 after the departure of Jeremy M. Berg, Ph.D., who had served as director since 2003.

"Dr. Greenberg is an exceptional leader, and I thank her for this service to NIGMS and NIH," said Collins.

As NIGMS director, Kaiser will oversee the institute's $2 billion budget, which primarily funds basic research in the areas of cell biology, biophysics, genetics, developmental biology, pharmacology, physiology, biological chemistry, bioinformatics and computational biology. NIGMS supports more than 4,500 research grantsabout 10 percent of those funded by NIH as a wholeas well as a substantial amount of research training and programs designed to increase the diversity of the biomedical and behavioral research workforce.

"In taking this position, I feel a compelling call to duty for national service and to be an advocate for the basic research enterprise," said Kaiser. "For 50 years, NIGMS has laid the foundation for important medical advances, and I'm excited to build on these efforts."

Kaiser's research uses genetic, biochemical and structural biology methods to understand the basic mechanisms of protein folding and intracellular transport, molecular processes essential to normal cell function. His efforts have led to the identification of numerous genes and related mutations involved in these processes. Kaiser is particularly interested in determining how secreted and other proteins form disulfide bonds, which are important for protein folding and stability. To study these questions, Kaiser uses yeast, a model organism for investigating mammalian genetics.

Kaiser has been an NIGMS grantee since 1992.

An initiative Kaiser said he's particularly eager to join is the institute's effort to build and sustain a strong and diverse scientific workforce, as outlined in the recent NIGMS strategic plan for research training. "Fostering scientific careers and improving workforce diversity are critical to research progress, and NIGMS has really taken a lead in this arena," said Kaiser, who oversaw an effort that increased graduate student diversity within the MIT biology department from 5 to 18 percent over six years.

Kaiser joined the MIT faculty in 1991 and became a full professor in 2002. He has chaired the biology department since 2004. He received an A.B. in biochemistry from Harvard University in 1980 and a Ph.D. in biology from MIT in 1987, then did postdoctoral research at the University of California, Berkeley.

Kaiser is co-author of a widely used textbook, Molecular Cell Biology (5th and 6th Editions). He has also organized Cold Spring Harbor scientific meetings, served on NIH review committees and been associate editor of the journal Molecular Biology of the Cell as well as a member of the editorial board for the journal Traffic.

His honors include a Markey scholarship (1990-1996), a Searle scholarship (1992-1996), the Whitehead Career Development professorship (1994-1997) and election as an American Association for the Advancement of Science fellow (2011). In 1999, he received MIT's highest teaching honor for the introductory genetics course he taught from 1992 to 2011.


'/>"/>

Contact: Ann Dieffenbach
dieffena@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
Source:Eurekalert  

Related biology news :

1. Robot biologist solves complex problem from scratch
2. NYU biologists use Sinatra-named fly to show how to see the blues -- and the greens
3. FSU biologists fish for reasons behind endangered groupers comeback
4. Pitt biologists find surprising number of unknown viruses in sewage
5. UC San Diego biologists discover genes that repair nerves after injury
6. Biologists discovery may force revision of biology textbooks
7. Team led by IU biologists confirms sunflower domesticated in US, not Mexico
8. Open minded and open access: NeoBiota, a new publishing platform for invasion biologists
9. Plant biologists dissect genetic mechanism enabling plants to overcome environmental challenge
10. Cell biologists hail stem cell decision
11. Retinal cells thoughts to be the same are not, JHU biologist says
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cell biologist Chris A. Kaiser to lead NIH's National Institute of General Medical Sciences
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... Feb. 2, 2016  Based on its recent ... Sullivan recognizes US-based Intelligent Retinal Imaging Systems (IRIS) ... Award for New Product Innovation. IRIS, a prominent ... North America , is poised to set ... diabetic retinopathy market. The IRIS technology presents superior ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of ... ended December 31, 2015. --> ... increased 2 percent compared to the comparable quarter last year to ... was $35.0 million, or $0.93 per diluted share. ... first quarter of fiscal 2016 grew 9 percent over the prior ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... , February 4, 2016 - New FDA action ... - New FDA action date of July 22, ... July 22, 2016   - ... in the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in ...
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... to be held February 8-9, 2016, at the Waldorf ... Growth & Healthcare Conference, taking place in ... James Sapirstein , Chief Executive Officer of ContraVir, ...
(Date:2/4/2016)... 2016 Strasbourg, France , ... --> Strasbourg, France , to the US ... is pleased to announce that it acted as an advisor ... in Strasbourg, France , to the US ... --> Transgene (Euronext: TNG), a member of ...
Breaking Biology Technology: